Full Breakdown
Detransitioner Testifies Before Senate Committee, Urges Ban on Child Transgender Procedures
7/22/2026, 9:01:32 PM
Core Event
Chloe Cole, a 21-year-old who began gender-affirming treatment at age 12 and underwent a double mastectomy at 15, appeared before the Senate Health, Education, Labor and Pensions (HELP) Committee. She urged Congress to enact a nationwide prohibition on sex-reassignment procedures for minors and to protect parents who refuse such interventions. Cole described ongoing physical pain, PTSD, and emotional numbness that she attributes to the interrupted development caused by hormone therapy, chemical castration drugs, and surgical removal of breast tissue.
Background & Context
Cole’s experience reflects a broader debate over the appropriateness of medical interventions for gender-nonconforming youth. Critics argue that children lack the capacity to consent to irreversible procedures, while supporters contend that early treatment can alleviate gender dysphoria and improve long-term wellbeing. The testimony came amid heightened public attention, including prior threats against Cole when she was scheduled to speak on a college campus.
Official Statements & Responses
During the hearing, Cole called for a federal ban on child transgender procedures, investigations of medical institutions that performed such care, and comprehensive treatment for harmed youths. Opposing her stance, Shannon Minter, legal director of the National Center for LGBTQ Rights, testified that the procedures are safe and effective, emphasizing that parents, not children, consent to medical care and are fully informed of risks. Minter also referenced Senator Bernie Sanders (I-VT), who has expressed that decisions about gender-affirming care should remain with parents, doctors, and the children themselves.
Criticism & Opposition
Minter’s testimony directly challenged Cole’s claim that doctors “prey on vulnerable children,” labeling the accusations as baseless attacks on legitimate medical practice. He argued that denying access to gender-affirming care would harm trans youth who benefit from early intervention.
Data & Statistics
- Age when treatment began: 12 years
- Age at double mastectomy: 15 years
- Current age: 21 years
- Reported health impacts: chronic hip and knee pain, PTSD, nightmares, emotional numbness
The hearing highlighted the deepening partisan divide over pediatric gender-affirming care and set the stage for potential legislative action.
